Cargando…
Hyperferritinemia Correlates to Metabolic Dysregulation and Steatosis in Chinese Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients
PURPOSE: Elevated serum ferritin (SF), also defined as hyperferritinemia, is commonly seen in patients with nonalcoholic fatty liver disease (NAFLD). However, the clinical significance of SF in NAFLD remains controversial. The aim of this study was to characterize the NAFLD patients with elevated SF...
Autores principales: | Wang, Qingling, Zhu, Mingyu, Li, Hu, Chen, Peizhan, Wang, Mingjie, Gu, Leilei, Zhang, Xinxin, Chen, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124058/ https://www.ncbi.nlm.nih.gov/pubmed/35607608 http://dx.doi.org/10.2147/DMSO.S361187 |
Ejemplares similares
-
Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease
por: Alsaif, Faisal A., et al.
Publicado: (2020) -
Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease
por: Arai, Taeang, et al.
Publicado: (2019) -
Serum Metabolites Are Associated With HFpEF in Biopsy‐Proven Nonalcoholic Fatty Liver Disease
por: Wegermann, Kara, et al.
Publicado: (2023) -
Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan
por: Tsai, Ming-Chao, et al.
Publicado: (2020) -
Hyperferritinemia
por: Kumachev, Alexander, et al.
Publicado: (2021)